Decrease of morphine-induced reward effects and withdrawal symptoms in mice overexpressing γ-aminobutyric acid transporter I

被引:12
作者
Hu, JH
Yang, N
Ma, YH
Zhou, XG
Zhang, XY
Jiang, J
Mei, ZT
Fei, JA
Guo, LH
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Physiol, Shanghai, Peoples R China
[3] Shanghai Res Ctr Biomodel Organism, Shanghai, Peoples R China
关键词
GABA transporter; morphine; dependence; transgenic mouse;
D O I
10.1002/jnr.10780
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Morphine addiction has been shown to result from neural adaptations produced by repeated drug exposure, but the mechanism is still unclear. In the present study, we found that gamma-aminobutyric acid (GABA) uptake was increased in mouse brain 120 min after, but not 20 min after, morphine (10 mg/kg, s.c.) injection. We generated GABA transporter I (GAT1)-overexpressing mice to investigate whether the GABAergic system and GABA transporter are involved in morphine-induced reward effects and withdrawal symptoms. Our results revealed that the rewarding effects induced by morphine were significantly decreased in GAT1-overexpressing mice as measured by the conditioned place preference (CPP) paradigm. Moreover, both somatic and vegetative signs of naloxone-induced morphine withdrawal symptoms were substantially reduced in GAT1-overexpressing mice. In addition, the decreased morphine rewarding in transgenic mice could be recovered when mice were coinjected with NO-711 (a GAT1 selective inhibitor) in the CPP paradigm. These findings suggest that the GABAergic system plays an important role in morphine addiction and point to the possibility of developing drugs that target GAT1 and extend the clinical application of opiates. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:614 / 621
页数:8
相关论文
共 36 条
[1]   NONVESICULAR RELEASE OF NEUROTRANSMITTER [J].
ATTWELL, D ;
BARBOUR, B ;
SZATKOWSKI, M .
NEURON, 1993, 11 (03) :401-407
[2]   ENDOGENOUS PAIN CONTROL-SYSTEMS - BRAIN-STEM SPINAL PATHWAYS AND ENDORPHIN CIRCUITRY [J].
BASBAUM, AI ;
FIELDS, HL .
ANNUAL REVIEW OF NEUROSCIENCE, 1984, 7 :309-338
[3]   Addiction, dopamine, and the molecular mechanisms of memory [J].
Berke, JD ;
Hyman, SE .
NEURON, 2000, 25 (03) :515-532
[4]   MECHANISM OF MU-OPIOID RECEPTOR-MEDIATED PRESYNAPTIC INHIBITION IN THE RAT HIPPOCAMPUS IN-VITRO [J].
CAPOGNA, M ;
GAHWILER, BH ;
THOMPSON, SM .
JOURNAL OF PHYSIOLOGY-LONDON, 1993, 470 :539-558
[5]   Transgenic animals with inducible, targeted gene expression in brain [J].
Chen, JS ;
Kelz, MB ;
Zeng, GQ ;
Sakai, N ;
Steffen, C ;
Shockett, PE ;
Picciotto, MR ;
Duman, RS ;
Nestler, EJ .
MOLECULAR PHARMACOLOGY, 1998, 54 (03) :495-503
[6]  
Chieng B, 1998, J NEUROSCI, V18, P7033
[7]   TRANSGENIC MICE EXPRESSING BETA-GALACTOSIDASE IN MATURE NEURONS UNDER NEURON-SPECIFIC ENOLASE PROMOTER CONTROL [J].
FORSSPETTER, S ;
DANIELSON, PE ;
CATSICAS, S ;
BATTENBERG, E ;
PRICE, J ;
NERENBERG, M ;
SUTCLIFFE, JG .
NEURON, 1990, 5 (02) :187-197
[8]   CLONING AND EXPRESSION OF A RAT-BRAIN GABA TRANSPORTER [J].
GUASTELLA, J ;
NELSON, N ;
NELSON, H ;
CZYZYK, L ;
KEYNAN, S ;
MIEDEL, MC ;
DAVIDSON, N ;
LESTER, HA ;
KANNER, BI .
SCIENCE, 1990, 249 (4974) :1303-1306
[9]   INVOLVEMENT OF D2 DOPAMINE-RECEPTORS IN THE NUCLEUS-ACCUMBENS IN THE OPIATE WITHDRAWAL SYNDROME [J].
HARRIS, GC ;
ASTONJONES, G .
NATURE, 1994, 371 (6493) :155-157
[10]   LOCAL AND DIFFUSE SYNAPTIC ACTIONS OF GABA IN THE HIPPOCAMPUS [J].
ISAACSON, JS ;
SOLIS, JM ;
NICOLL, RA .
NEURON, 1993, 10 (02) :165-175